MustGrow Biologics Corp.
MGRO.V · TSXV
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 1.08 | -0.55 | 2.30 |
| FCF Yield | -6.03% | -0.46% | -1.88% | -1.55% |
| EV / EBITDA | -11.12 | -86.13 | -30.10 | -48.76 |
| Quality | ||||
| ROIC | -175.56% | -12.69% | -92.62% | -32.71% |
| Gross Margin | 75.56% | 91.84% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.73 | 0.44 | 0.59 | 0.79 |
| Growth | ||||
| Revenue 3-Year CAGR | 294.58% | 615.42% | – | – |
| Free Cash Flow Growth | -1,113.97% | 90.95% | -35.07% | 6.48% |
| Safety | ||||
| Net Debt / EBITDA | 0.48 | 8.95 | 1.13 | 2.95 |
| Interest Coverage | 0.00 | 0.00 | -551.93 | -57.07 |
| Efficiency | ||||
| Inventory Turnover | 0.07 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -3,932.02 | -297.94 | 4,945.61 | 1,823.61 |